{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T23:51:22Z","timestamp":1725753082880},"reference-count":13,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T00:00:00Z","timestamp":1095984000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p> <jats:italic>We report the case of a patient in whom radiofrequency catheter ablation of the AV node was initially successfully performed for persistant atrial fibrillation with fast ventricular rate, but in whom atrioventricular conduction transiently resumes following therapy with levosimendan. Plausible hypothesis are discussed as well as potential implications.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2004.00626.x","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T15:45:47Z","timestamp":1096040747000},"page":"1314-1316","source":"Crossref","is-referenced-by-count":3,"title":["Resumption of Atrioventricular Conduction by Levosimendan After Radiofrequency Ablation of the AV Node:"],"prefix":"10.1111","volume":"27","author":[{"given":"PHILIPPE","family":"MAURY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CECILE","family":"BAIXAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JEROME","family":"RONCALLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PHILIPPE","family":"COUDERC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARC","family":"DELAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATHUL","family":"PATHAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHEL","family":"GALINIER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,24]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013385305567"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01350-4"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200104000-00003"},{"key":"e_1_2_4_5_2","first-page":"375","article-title":"The novel calcium sensitizer levosimendan activates the ATP\u2010sensitive K+ channel in rat ventricular cells","volume":"283","author":"Yokoshiki H","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01108-4"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1831"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01569-2"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(95)02060-8"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200004000-00021"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002042001005"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP40465"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000043245.00859.11"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.2.262"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2004.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2004.00626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T21:50:04Z","timestamp":1694382604000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2004.00626.x"}},"subtitle":["Does Levosimendan Have Potential as Medical Therapy in Atrioventricular Conduction Disease?"],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1540-8159.2004.00626.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2004.00626.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}